Interventional lung centre
Page Content
Current projects
Post-Market Registry for Patients with Emphysema
Treated with Bronchoscopic Thermal Vapor Ablation (BTVA) | 2018-01071 | |
BAL-Biobank for Non-Lung Transplanted Patients
with Various Pulmonary Diseases | 2017-02307 | |
Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV for Bronchoscopic Lung Volume Reduction (BLVR) Procedures
| 2019-01044 | |
Value of Bronchoscopic Lung Volume Reduction by Valve Implantation in Patients with Severe Pulmonary Emphysema
| 2018-0238 | |
Improvement of Cardiovascular Function after Bronchoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema. A Randomized Controlled Trial.
| 2019-01682 | |
Endobronchial Ultrasound-guided Forceps Biopsy versus Needle Aspiration of Mediastinal and Hilar Lymphadenopathy: A Retrospective Analysis.
| 2019-02479 | |
Surgical compared to bronchoscopic lung volume reduction in patients with severe emphysema: a multi-center randomized controlled trial (SINCERE)
| 2020-00562
| |
Information
Tel +41 44 255 97 50
daniel.franzen@usz.ch
Team
Dr Daniel Franzen, MD, Senior Attending Physician
Contact address
Department of Pulmonology
PD Dr Daniel Franzen, MD
University Hospital Zurich
Rämistrasse 100
8091 Zurich
